Modeling the incubation period of inhalational anthrax

Medical Decision Making

Volumn 28, Issue 4, 2008, Pages 593-605

  Wilkening, Dean A ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Anthrax; Bioterrorism; Incubation period; Medical response; Models

Indexed keywords

ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL GROWTH; BIOLOGICAL WARFARE; DEATH; INCUBATION TIME; INHALATION; PRIMATE; PROPHYLAXIS; RUSSIAN FEDERATION; SPORE GERMINATION; SYMPTOM; THEORETICAL MODEL;

ANIMALS; ANTHRAX; BACILLUS ANTHRACIS; BIOLOGICAL WARFARE; BIOTERRORISM; HUMANS; INHALATION EXPOSURE; MACACA MULATTA; MODELS, BIOLOGICAL; SPORES, BACTERIAL;

EID: 47249108543     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X08315245     Document Type: Article

References (37)

1. Sartwell P. The distribution of incubation periods of infectious diseases. Am J Hygiene. 1950 ; 51: 310-8.
2. Brookmeyer R., Johnson E., Barry S. Modelling the incubation period of anthrax. Stat Med. 2005 ; 54: 531-42.
3. Pile JC, Malone JD, Eitzen EM, Friedlander AM Anthrax as a potential biological warfare agent. Arch Intern Med. 1998 ; 158: 429-34.
4. Friedlander AM Anthrax. In: Zajtchuk R, ed. Medical Aspects of Chemical and Biological Warfare: Textbook of Military Medicine, Part I. Falls Church (VA): Office of the Surgeon General, US Army ; 1997.
5. Watson A., Keir D. Information on which to base assessments of risk from environments contaminated with anthrax spores. Epidemiol Infect. 1994 ; 113: 479-90.
6. Inglesby TV, Henderson DA, Bartlett JG, et al. Anthrax as a biological weapon. JAMA. 1999 ; 281: 1735-45.
7. Inglesby TV, O'Toole T., Henderson DA, et al. Anthrax as a biological weapon, 2002. JAMA. 2002 ; 287: 2236-52.
8. Druett HA, Henderson DW, Packman L., Peacock S. Studies on respiratory infection: I. The influence of particle size on respiratory infection with anthrax spores. J Hyg. 1953 ; 51: 359-71.
9. Glassman H. Discussion. Bacteriol Rev. 1966 ; 30: 657-9.
10. Holty JC, Bravata DM, Liu H., Olshen RA, McDonald KM, Owens DK Systematic review: a century of inhalational anthrax cases from 1900 to 2005. Ann Intern Med. 2006 ; 144: 270-80.
11. Brachman PS, Kaufmann AF, Dalldorf FG Industrial inhalation anthrax. Bacteriol Rev. 1996 ; 30: 646-57.
12. Brachman PS, Plotkin SA, Bumford FH, Atchison MM An epidemic of inhalation anthrax: the first in the twentieth century. Am J Hyg. 1960 ; 72: 6-23.
13. Albrink WS, Brooks SM, Biron RE, Kopel M. Human inhalation anthrax: a report of three fatal cases. Am J Pathol. 1960 ; 36: 457-71.
14. Agranovski IE, Pyankov OV, Altman IS Bioaerosol contamination of ambient air as the result of opening envelopes containing microbial materials. Aerosol Sci Technol. 2005 ; 39: 1048-55.
15. Meselson M., Guillemin J., Hugh-Jones M., et al. The Sverdlovsk anthrax outbreak of 1979. Science. 1994 ; 266: 1202-8.
16. Guillemin J. Anthrax: Investigation of a Deadly Outbreak. Berkeley: University of California Press ; 1999.
17. Brookmeyer R., Blades N., Hugh-Jones M., Henderson DA The statistical analysis of truncated data: application to the Sverdlovsk anthrax outbreak. Biostatistics. 2001 ; 2: 233-47.
18. Jackson PJ, Hugh-Jones ME, Adair DM, et al. PCR analysis of tissue samples for the 1979 Sverdlovsk anthrax victims: the presence of multiple Bacillus anthracis strains in different victims. Proc Natl Acad Sci USA. 1998 ; 95: 1224-9.
19. Wilkening D. Sverdlovsk revisited: modeling human inhalation anthrax. Proc Natl Acad Sci USA. 2006 ; 103: 7589-94.
20. Franz DR, Jahrling PB, Friedlander AM, et al. Clinical recognition and management of patients exposed to biological warfare agents. JAMA. 1997 ; 278: 399-411.
21. Tigertt WD, Benenson AS, Gochenour WS Airborne Q-fever. Microbiol Mol Biol Rev. 1961 ; 25: 285-93.
22. Gleiser CA, Berdjis CC, Hartman HA, Gochenour WS Pathology of experimental respiratory anthrax in Macaca mulatta. Br J Exp Pathol. 1963 ; 44: 416-26.
23. Anno GH, Deverill AP Consequence analytic tools for NBC operations. Defense Special Weapons Agency Rep. DSWA-TR-97-61-V1, 1998.
24. Kondo K. The lognormal distribution of the incubation time of exogenous diseases: genetic interpretations and computer simulation. Jpn J Hum Genet. 1977 ; 21: 217-37.
25. Tager IB Health effects of aerosols: mechanisms and epidemiology. In: Ruzer LS, Harley NH, eds. Aerosols Handbook: Measurement, Dosimetry, and Health Effects. Boca Raton (FL): CRC Press; 2005.
26. Subcommittee on Airborne Particles, National Research Council Committee on Medical and Biologic Effects of Environmental Pollutants. Airborne Particles. Baltimore (MD): University Park Press ; 1979.
27. Heyder J., Gebhart J., Rudolf G., Schiller CF, Stahlhofen W. Deposition of particles in the human respiratory tract in the size range 0.005-15 μm. J Aerosol Sci. 1986 ; 17: 811-25.
28. Fritz DL, Jaax NK, Lawrence WB, et al. Pathology of experimental inhalation anthrax in the rhesus monkey. Lab Invest. 1995 ; 73: 691-702.
29. Ivins BE, Pitt MLM, Fellows PF, et al. Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macques. Vaccine. 1998 ; 16: 1141-8.
30. Ivins BE, Fellows PF, Pitt MLM, et al. Efficacy of a standard human anthrax vaccine against Bacillus anthracis aerosol spore challenge in rhesus monkeys. Salisbury Med Bull. 1996 ; 87 (suppl): 125-6.
31. Henderson DW, Peacock S., Belton FC Observations on the prophylaxis of experimental pulmonary anthrax in the monkey. J Hyg. 1956 ; 54: 28-36.
32. Albrink WS Pathogensis of inhalation anthrax. Bacteriol Rev. 1961 ; 25: 268-73.
33. Friedlander AM, Welkos SL, Pitt MLM, et al. Postexposure prophylaxis against experimental inhalation anthrax. J Infect Dis. 1993 ; 167: 1239-42.
34. Press WH, Teukolosky SA, Vetterling WT, Flannery BP Numerical Recipes in C++: The Art of Scientific Computing. 2 nd ed. Cambridge, UK: Cambridge University Press ; 2002.
35. Buckeridge DL, Owens DK, Switzer P., Frank J., Musen M. Evaluating detection of an inhalational anthrax outbreak. Emerg Infect Dis. 2006 ; 12: 1942-9.
36. Jernigan JA, Stephens DS, Ashford DA, et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis. 2001 ; 7: 933-44.
37. Brookmeyer R., Johnson E., Bollinger R. Modeling the optimum duration of antibiotic prophylaxis in an anthrax outbreak. Proc Natl Acad Sci USA. 2003 ; 100: 10129-32.